SUMMARY:
The patient with Charcot-Marie-Tooth disease or HSMN1 and advanced Hodgkin lymphoma undergoing treatment with modified BEACOPP achieving complete remission without major aggravation of neurological symptoms.
TITLE:
Effective treatment of advanced Hodgkin lymphoma with a modified BEACOPP regimen for a patient with demyelinating hereditary motor and sensory neuropathy type 1 (HMSN1)
DESCRIPTION:
Treatment for Hodgkin lymphoma (HL) in adults comprises substantial risk of chemotherapy-induced peripheral neurotoxicity. Here, we describe the case of patient with Charcot-Marie-Tooth disease or HSMN1 and advanced Hodgkin lymphoma undergoing treatment with modified BEACOPP achieving complete remission without major aggravation of neurological symptoms.
CONTENT:
Clin Case Rep. 2022 May 5;10(5):e05766. doi: 10.1002/ccr3.5766. eCollection 2022 May.
ABSTRACT
Treatment for Hodgkin lymphoma (HL) in adults comprises substantial risk of chemotherapy-induced peripheral neurotoxicity. Here, we describe the case of patient with Charcot-Marie-Tooth disease or HSMN1 and advanced Hodgkin lymphoma undergoing treatment with modified BEACOPP achieving complete remission without major aggravation of neurological symptoms.
PMID:35540715 | PMC:PMC9069391 | DOI:10.1002/ccr3.5766
SOURCE:
Clinical case reports
TAGS:
HSMN1 BEACOPP
CATEGORY:
Research
SUBCATEGORY:
n/a
DATE – PUBLISHED:
2022-05-05T08:46:05Z
DATE – DOI: 2022-05-05T08:46:05Z
DATE – PUBMED: 2022 May 5
DATE OUTPUT MATCHED: True
DATE – ADDED:
Wed, 11 May 2022 06:00:00 -0400
DATE – RETRIEVED:
05/11/22 07:45AM
2022-05-11T07:45:17-04:00
FEATURED IMAGE:
Media Uploaded (image/png)
IDENTIFIER:
pmid:35540715,pmc:PMC9069391,doi:10.1002/ccr3.5766
PUBMED ID:
pubmed:35540715
DOI:
10.1002/ccr3.5766
LINK – PUBMED:
https://pubmed.ncbi.nlm.nih.gov/35540715/
LINK – DOI:
https://doi.org/10.1002/ccr3.5766
LINK – PUBLISHER:
https://onlinelibrary.wiley.com/doi/10.1002/ccr3.5766
REFERENCES:
CMT Treatment Report, Urgent Research, 2022-05-11T07:45:17-04:00, https://www.cmttreatmentreport.com.
